Please login to the form below
Myovant Sciences
This page shows the latest Myovant Sciences news and features for those working in and with pharma, biotech and healthcare.
FDA approves Myovant’s oral pill Orgovyx for prostate cancer
The US Food and Drug Administration (FDA) has approved Myovant’s once-daily pill Orgovyx for prostate cancer. ... day,” said Lynn Seely, chief executive officer of Myovant Sciences.
Latest news
-
Takeda forms new women's health and cancer company
Myovant Sciences will focus on delivering innovative therapies in the two areas, with former Medivation chief medical officer Lynn Seely appointed to lead the business. ... For its tie-up with Takeda, the Japanese firm has granted Myovant Sciences an
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- UK pharmacies to begin administering COVID-19 vaccinations
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- PHE study finds people who have had COVID-19 can still transmit the virus
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Research Partnership appoints Hannah Osborn to MedTech director role
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- NHS is set to begin offering COVID-19 vaccinations to over-70s this week
- Cambridge University develops DNA test for secondary infections in COVID-19 patients
- 2020 - a year to remember or forget?
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
PMHub
TRIDUCIVE
Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...
Latest intelligence
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Quick links
Infographics
